Previous 10 | Next 10 |
2024-05-08 11:40:40 ET More on Charles River Laboratories Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Charles River, Axovia to collaborat...
2024-05-05 09:52:16 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Dovish Fed, 'Goldilocks' jobs report helps S&P 500 notch back-to-back weekly gains...
Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developers Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (...
2024-04-29 13:17:15 ET More on S&P 500 Index: Soft Landing On Track, With New All-Time Highs Ahead Yen Dumps Before It Jumps S&P 500: Trade Of The Year. Week Starting 29th April (Technical Analysis) Nasdaq, S&P, and Dow rise with the latest Fed de...
2024-04-29 08:47:01 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.81 Iterum spikes on accelerated timeline for FDA filing Seeking Alpha’s Quant Rating on Iterum Th...
2024-04-28 15:24:54 ET Marathon Petroleum ( MPC ), 63 Coterra Energy ( CTRA ), 60 Info Tech... Read the full article on Seeking Alpha For further details see: With rate cuts pushed out, Goldman looks at quality stocks
2024-04-25 17:01:08 ET Summary Danaher Corporation stock has surged by 16% since our "Strong Buy" rating in June 2023, outperforming the S&P 500. The bioprocessing industry is facing near-term challenges, but long-term growth prospects remain strong. Danaher's Q1 FY24 resu...
Company marks significant progress towards climate goals, reaching the milestone considerably ahead of schedule Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quar...
2024-04-18 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Initiative focuses on innovation, partnerships, and advocacy as part of $500 million investment in driving change Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated t...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...